Skip to main content

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1086619 London, X0

Position in SUPN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$9,101,368
-$338,749 QoQ
Shares Held
176,076
-7.3% QoQ
Ownership
0.303%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $254,809,935 across 13 Drug Manufacturers - Specialty & Generic names. SUPN ranks #7 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 SUPN
Supernus Pharmaceuticals, Inc.
This page
176,076 $9,101,368

All Filings in SUPN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,101,368 176,076
2025-12-31 $9,440,117 189,942
2025-06-30 $8,413,539 266,927
2025-03-31 $8,825,470 269,480
2024-12-31 $10,799,437 298,657
2024-09-30 $16,066,960 515,297
2024-06-30 $13,591,594 508,097
2024-03-31 $12,200,498 357,681
2023-12-31 $15,684,698 541,973
2020-06-30 $32,300 1,360
2020-03-31 $220,557 12,260